VIMAX
Price
$331.89
Change
+$5.20 (+1.59%)
Updated
Dec 20 closing price
VIMSX
Price
$73.16
Change
+$1.15 (+1.60%)
Updated
Dec 20 closing price
Ad is loading...

VIMAX vs VIMSX

Header iconVIMAX vs VIMSX Comparison
Open Charts VIMAX vs VIMSXBanner chart's image
Vanguard Mid Cap Index Admiral
Price$331.89
Change+$5.20 (+1.59%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$73.16
Change+$1.15 (+1.60%)
VolumeN/A
CapitalizationN/A
VIMAX vs VIMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VIMAX vs. VIMSX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIMAX is a Buy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMAX (190B) and VIMSX (190B) have equal amount of cash in the bank . VIMAX pays higher dividends than VIMSX: VIMAX (1.49) vs VIMSX (1.38). VIMAX was incepted earlier than VIMSX: VIMAX (23 years) vs VIMSX (27 years). VIMAX (13.00) and VIMSX (13.00) have comparable annual turnover. VIMAX (3000) and VIMSX (3000) have matching initial minimum investment requirements. VIMAX (16.47) and VIMSX (16.42) have marching annual gain over last year. VIMAX (51.69) and VIMSX (51.60) have equivalent 5 years return.
VIMAXVIMSXVIMAX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years27 years-
Gain YTD15.45015.413100%
Front LoadN/AN/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets190B190B100%
Annual Yield % from dividends1.491.38108%
Returns for 1 year16.4716.42100%
Returns for 3 years8.118.08100%
Returns for 5 years51.6951.60100%
Returns for 10 years119.36119.08100%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDTC2.560.12
+4.92%
CytoMed Therapeutics Limited
AQN4.390.08
+1.86%
Algonquin Power & Utilities Corp
EBAY65.011.06
+1.66%
eBay
DOLE13.70-0.11
-0.80%
Dole plc
BNTC11.41-0.76
-6.24%
Benitec Biopharma